Clinical Trial Update: Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for masitinib in primary progressive or relapse-free secondary progressive multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED